Author:
Le Page Anne Laure,Ballot Elise,Truntzer Caroline,Derangère Valentin,Ilie Alis,Rageot David,Bibeau Frederic,Ghiringhelli Francois
Abstract
AbstractHistological stratification in metastatic non-small cell lung cancer (NSCLC) is essential to properly guide therapy. Morphological evaluation remains the basis for subtyping and is completed by additional immunohistochemistry labelling to confirm the diagnosis, which delays molecular analysis and utilises precious sample. Therefore, we tested the capacity of convolutional neural networks (CNNs) to classify NSCLC based on pathologic HES diagnostic biopsies. The model was estimated with a learning cohort of 132 NSCLC patients and validated on an external validation cohort of 65 NSCLC patients. Based on image patches, a CNN using InceptionV3 architecture was trained and optimized to classify NSCLC between squamous and non-squamous subtypes. Accuracies of 0.99, 0.87, 0.85, 0.85 was reached in the training, validation and test sets and in the external validation cohort. At the patient level, the CNN model showed a capacity to predict the tumour histology with accuracy of 0.73 and 0.78 in the learning and external validation cohorts respectively. Selecting tumour area using virtual tissue micro-array improved prediction, with accuracy of 0.82 in the external validation cohort. This study underlines the capacity of CNN to predict NSCLC subtype with good accuracy and to be applied to small pathologic samples without annotation.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Hanna, N. H. et al. Therapy for stage IV non-small-cell lung cancer without driver alterations: ASCO and OH (CCO) Joint Guideline Update. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 38, 1608–1632 (2020).
2. Hanna, N. H. et al. Therapy for stage IV non-small-cell lung cancer with driver alterations: ASCO and OH (CCO) Joint Guideline Update. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 39, 1040–1091 (2021).
3. Bernicker, E. H., Miller, R. A. & Cagle, P. T. Biomarkers for selection of therapy for adenocarcinoma of the lung. J. Oncol. Pract. 13, 221–227 (2017).
4. Travis, W. D. et al. The 2015 World Health Organization classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification. J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer 10, 1243–1260 (2015).
5. Vanderlaan, P. A. et al. Success and failure rates of tumor genotyping techniques in routine pathological samples with non-small-cell lung cancer. Lung Cancer Amst. Neth. 84, 39–44 (2014).
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献